Pulmonary Hypertension: Pre-clinical Research on New Molecular Targets and Therapeutic Strategies
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 20 June 2024 | Viewed by 1356
Special Issue Editor
Interests: pulmonary arterial hypertension; right ventricle function; animal models; receptor tyrosine kinase signalling; bone morphogenetic protein receptor type 2; heart failure
Special Issue Information
Dear Colleagues,
Pulmonary hypertension is a disorder with a complex pathophysiology that can be associated with multiple conditions, including primary vascular disease, heart failure, interstitial lung disease, thromboembolic disease, or other multifactorial or unknown causes.
While an earlier diagnosis and combinational therapies promote a better prognosis, it is still associated with a worse quality of life and survival.
In recent years, significant efforts, including the description of new signalling pathways and genetic mutations associated with the disease, the development of new animal models, and new therapeutic interventions, have resulted in generating a better understanding of the disease. Despite that, new efficacious treatments are still being developed, specifically ones that can halt disease progression and the deadly development of right ventricular failure.
In this Special Issue, we aim to highlight basic and translational research that can move the field of PH forward, by describing new pathways to be targeted, defining new therapeutic strategies, creating new animal models, or better characterizing the disease both at pulmonary and cardiac levels.
Dr. Pedro Mendes-Ferreira
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pulmonary hypertension
- right ventricle
- animal models
- heart failure
- pulmonary arterial hypertension
